A
Anastasia Slobodnick
Researcher at New York University
Publications - 7
Citations - 538
Anastasia Slobodnick is an academic researcher from New York University. The author has contributed to research in topics: Gout & Cancer. The author has an hindex of 4, co-authored 7 publications receiving 372 citations. Previous affiliations of Anastasia Slobodnick include New York Eye and Ear Infirmary & Columbia University.
Papers
More filters
Journal ArticleDOI
Colchicine: Old and New
TL;DR: The use of colchicine in a variety of illnesses, including rheumatic and, most recently, cardiovascular diseases, is discussed and the pharmacologic properties of the drug are discussed.
Journal ArticleDOI
Update on colchicine, 2017.
Anastasia Slobodnick,Anastasia Slobodnick,Binita Shah,Binita Shah,Svetlana Krasnokutsky,Svetlana Krasnokutsky,Michael H. Pillinger,Michael H. Pillinger +7 more
TL;DR: The evidence for the well-established use of colchicine in gout is reviewed, and the potential benefit in cardiac disease, including coronary artery disease in patients both with and without gout, is highlighted.
Journal ArticleDOI
Early Glaucoma Involves Both Deep Local, and Shallow Widespread, Retinal Nerve Fiber Damage of the Macular Region
Donald C. Hood,Anastasia Slobodnick,Anastasia Slobodnick,Anastasia Slobodnick,Ali S. Raza,Carlos Gustavo De Moraes,Carlos Gustavo De Moraes,Christopher C. Teng,Christopher C. Teng,Robert Ritch,Robert Ritch +10 more
TL;DR: Optical coherence tomography scans of the circumpapillary RNFL and the macular RGC+ layer can aid in the identification of these defects and help in the interpretation of 24-2 and 10-2 VF tests.
Journal ArticleDOI
Colchicine Use and Incident Coronary Artery Disease in Male Patients With Gout.
Binita Shah,Michael Toprover,Daria B. Crittenden,Susanna Jeurling,Susanna Jeurling,V. Courtney Pike,Svetlana Krasnokutsky,Yuhe Xia,Mark Fisher,Anastasia Slobodnick,Craig Tenner,Stuart D. Katz,Michael H. Pillinger +12 more
TL;DR: In male patients with gout and no known CAD, a trend of reduced incident CAD was observed with colchicine use that was not statistically significant, and larger, prospective studies will be required to definitively assess the primary prevention benefit of col chicine.
Journal ArticleDOI
Allopurinol use and type 2 diabetes incidence among patients with gout: A VA retrospective cohort study.
Anastasia Slobodnick,Michael Toprover,Jeff Greenberg,Daria B. Crittenden,Virginia C. Pike,Yingzhi Qian,Hua Zhong,Michael H. Pillinger +7 more
TL;DR: In this study, allopurinol use was not associated with decreased diabetes incidence, and Prospective studies may further elucidate the relationship between hyperuricemia, gout, xanthine oxidase activity, and diabetes, and the potential impact of gout treatments on diabetes incidence.